glp 1 trial Timeline of GLP-1 discovery and clinical development. (a) Key events in GLP-1 Medications for Weight Loss:

Edited by: Marilena Vitale, Federico II University Hospital, Italy Reviewed by: Theodoros Androutsakos, National and Kapodistrian University of Athens, Greece Gianpaolo Zerbini, San Raffaele Hospital (IRCCS), Italy Giovanna DAbbronzo, Federico II University Hospital, Italy Abbreviations: AgRP, agouti-related protein

Regardless of which type of GLP-1 you are using, the principles of titration remain the same

Payment is charged to your Google Play account at confirmation of purchase

Diabetes 62, 20882094 (2013)

People with type 1 diabetes should not use GLP-1 medications as their primary treatment, though they may sometimes be used as additional therapy under careful medical supervision

Cork, PhD, study co-author, physiologist, and senior lecturer in the School of Medicine at Anglia Ruskin University